The global Veterinary Point Of Care Diagnostics market size is expected to be worth around US$ 5.69 billion by 2030, according to a new report by Vision Research Reports.
The global Veterinary Point Of Care Diagnostics market size was valued at US$ 2.15 billion in 2020 and is anticipated to grow at a CAGR of 12.3% during forecast period 2021 to 2030.
Report Coverage
Report Scope | Details |
Market Size | US$ 5.69 billion by 2030 |
Growth Rate | CAGR of 12.3% From 2021 to 2030 |
Largest Market | North America |
Base Year | 2021 |
Forecast Period | 2021 to 2030 |
Segments Covered | Animal Type, Product, Sample type, Testing category, Indication, End use |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Mentioned | IDEXX Laboratories; Zoetis; Virbac; Heska Corporation; Thermo Fisher Scientific, Inc.; Neogen Corporation; Mindray; Esaote SpA; FUJIFILM Corporation; Woodley Equipment Company Ltd. |
Growth Factors
Technological advancements, strategic initiatives by key market players, rising pet population and humanization, the need to reduce antimicrobial resistance, and the expansion of service offerings by vet clinics are key factors driving the market. Heska, for instance, allocates its R&D budget for developing new Analyzer and Diagnostics Platforms, expanding the menu of analyzer platforms, upgrading the cycle to already installed platforms, and other in-house inventions. The market witnessed a slowdown in sales, reduced demand, and logistical challenges due to the COVID-19 pandemic. The uncertainty was exacerbated by the changing lockdown measures, guidelines on the movement of people and goods, remote work, and self-quarantine conditions.
Several key animal health companies also registered increased profits during 2020. This was owing to the deployment of various strategic initiatives such as diverting their resources to profitable segments to ensure business continuity, acquisitions, and the launch of new products. Heska, for instance, reported 97.4% of growth in its revenue during the first quarter of 2021. IDEXX Laboratories, Inc. reported a 12% increase in year-on-year revenue, driven by the Companion Animal Group (CAG) diagnostics segment, during 2020.
By Sample Type Analysis
The blood/plasma/serum segment held the largest revenue share of over 40.0% in 2020. According to the Kirkwood Animal Hospital in the U.S., regular blood tests are recommended as a key part of a companion animal’s overall wellness program.
The urine segment is expected to grow at the fastest rate over the forecast period. For instance, ACON Laboratories, Inc. offers CentriVet URS Reagent Strips for Urinalysis.
The reagent strips can be used for detecting 10 parameters, including bilirubin and urobilinogen for signs of liver disease, leukocytes and nitrites for urinary tract infections, and glucose and ketone for diabetes mellitus.
By Product Analysis
The consumables, reagents, and kits segment accounted for the largest share of more than 55.0% in 2020. This is owing to large product availability, subscription-based or repetitive payments sales model for reagents and consumables, and other initiatives by key companies.
The instruments and devices segment is projected to expand at the fastest rate of over 11.6% in the forecast period owing to growing product enhancements and demand for these products. Pentra C400 clinical chemistry analyzer by HORIBA, Ltd., based in Japan, for instance, can be used for routine to specific tests owing to its 55 on-board assays.
By Testing Category Analysis
Parasitology dominated the market with a revenue share of over 17.0% in 2020. The hematology segment is estimated to expand at the fastest CAGR of 12.0% over the forecast period.
Zoetis, for instance, launched Imagyst in 2020 to enable vets to make fast and accurate diagnoses at the point of care by automating the fecal examination to detect endoparasitic eggs, cysts, and oocysts.
By End-use Analysis
Veterinary hospitals and clinics held the largest revenue share of over 50.0% in 2020. This is attributed to a higher volume of patients received in these facilities, growing adoption of point of care devices by vet clinics, and wide diagnostic services offerings.
The home care settings segment is expected to register the highest growth rate of 12.9% from 2021 to 2030 due to the rising product launches in this category and pet expenditure.
By Animal Type Analysis
Companion animals dominated the market with a revenue share of over 60.0% in 2020. The livestock animals segment is projected to grow at the fastest rate over the forecast period.
This is attributed to the rising pet population, increasing expenditure, growing adoption of pet insurance, and the need to secure food sources by safeguarding the health of livestock animals.
Dogs and cats, for example, dominate the pet population in the U.S. as per the National Pet Owners Survey of 2019 to 2020 by the American Pet Products Association (APPA). Americans were estimated to have spent over USD 100 billion on pets in 2020.
By Indication Analysis
The infectious disease segment held the largest revenue share of about 40.0% in 2020. The general ailments segment is estimated to expand at the highest rate of 11.4% over the forecast period.
The key factors contributing to this growth include the growing prevalence of acute and chronic diseases in animals, the longer lifespan of pets, product advancements, and pet humanization.
Independent Vetcare Ltd.’s South Devon Veterinary Hospital in the U.K. offers a full range of diagnostic endoscopy services using flexible and rigid endoscopes as well as video endoscopes.
By Regional Analysis
North America held the largest revenue share of over 50.0% in 2020. The regional market growth can be attributed to the presence of key market players and advanced veterinary health care infrastructure in the U.S. and Canada.
North America held the largest revenue share of over 50.0% in 2020. The regional market growth can be attributed to the presence of key market players and advanced veterinary health care infrastructure in the U.S. and Canada.
Key Players
IDEXX Laboratories
Zoetis
Virbac
Heska Corporation
Thermo Fisher Scientific, Inc.
Neogen Corporation
Mindray
Esaote SpA
FUJIFILM Corporation
Woodley Equipment Company Ltd.
Market Segmentation
By Animal Type
Companion Animals
Dogs
Cats
Horses
Others
Livestock Animals
Cattle
Swine
Poultry
Others
By Product
Consumables, Reagents, & Kits
Instruments & Devices
By Sample Type
Blood/Plasma/Serum
Urine
Fecal
Others
By Testing Category
Hematology
Diagnostic Imaging
Bacteriology
Virology
Cytology
Clinical Chemistry
Parasitology
Serology
Others
By Indication
Infectious Disease
General Ailments
Others
By End-use
Veterinary Hospitals & Clinics
Home Care Settings
Others
Regional
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
Israel
The Veterinary Point Of Care Diagnostics market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Veterinary Point Of Care Diagnostics market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Veterinary Point Of Care Diagnostics market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Veterinary Point Of Care Diagnostics market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Veterinary Point Of Care Diagnostics market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Veterinary Point Of Care Diagnostics capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Veterinary Point Of Care Diagnostics by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Veterinary Point Of Care Diagnostics market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Veterinary Point Of Care Diagnostics market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Veterinary Point Of Care Diagnostics market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Veterinary Point Of Care Diagnostics industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Veterinary Point Of Care Diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Veterinary Point Of Care Diagnostics market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Veterinary Point Of Care Diagnostics market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Veterinary Point Of Care Diagnostics market. These factors have benefited the growth of the global market for Veterinary Point Of Care Diagnostics. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Veterinary Point Of Care Diagnostics. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Veterinary Point Of Care Diagnostics are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Veterinary Point Of Care Diagnostics Market, By Animal Type
7.1. Veterinary Point Of Care Diagnostics Market, by Animal Type, 2021-2030
7.1.1. Companion Animals
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Livestock Animals
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Veterinary Point Of Care Diagnostics Market, By Product
8.1. Veterinary Point Of Care Diagnostics Market, by Product, 2021-2030
8.1.1. Consumables, Reagents, & Kits
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Instruments & Devices
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Veterinary Point Of Care Diagnostics Market, By Sample Type
9.1. Veterinary Point Of Care Diagnostics Market, by Sample Type, 2021-2030
9.1.1. Blood/Plasma/Serum
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Urine
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Veterinary Point Of Care Diagnostics Market, By Testing Category
10.1. Veterinary Point Of Care Diagnostics Market, by Testing Category, 2021-2030
10.1.1. Hematology
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Diagnostic Imaging
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Bacteriology
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Virology
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Cytology
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Virology
10.1.6.1. Market Revenue and Forecast (2017-2030)
10.1.7. Clinical Chemistry
10.1.7.1. Market Revenue and Forecast (2017-2030)
10.1.8. Parasitology
10.1.8.1. Market Revenue and Forecast (2017-2030)
10.1.9. Serology
10.1.9.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Veterinary Point Of Care Diagnostics Market, By Indication
11.1. Veterinary Point Of Care Diagnostics Market, by Indication, 2021-2030
11.1.1. Infectious Disease
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. General Ailments
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Veterinary Point Of Care Diagnostics Market, By End-use
12.1. Veterinary Point Of Care Diagnostics Market, by End-use, 2021-2030
12.1.1. Veterinary Hospitals & Clinics
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Home Care Settings
12.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Veterinary Point Of Care Diagnostics Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.1.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.1.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.1.5. Market Revenue and Forecast, by Indication (2017-2030)
13.1.6. Market Revenue and Forecast, by End-use (2017-2030)
13.1.7. U.S.
13.1.7.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.1.7.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.1.7.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.1.7.5. Market Revenue and Forecast, by Indication (2017-2030)
13.1.7.6. Market Revenue and Forecast, by End-use (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.1.8.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.1.8.5. Market Revenue and Forecast, by Indication (2017-2030)
13.1.8.6. Market Revenue and Forecast, by End-use (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.2.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.2.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.2.5. Market Revenue and Forecast, by Indication (2017-2030)
13.2.6. Market Revenue and Forecast, by End-use (2017-2030)
13.2.7. UK
13.2.7.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.2.7.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.2.7.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.2.7.5. Market Revenue and Forecast, by Indication (2017-2030)
13.2.7.6. Market Revenue and Forecast, by End-use (2017-2030)
13.2.8. Germany
13.2.8.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.2.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.2.8.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.2.8.5. Market Revenue and Forecast, by Indication (2017-2030)
13.2.8.6. Market Revenue and Forecast, by End-use (2017-2030)
13.2.9. France
13.2.9.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.2.9.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.2.9.5. Market Revenue and Forecast, by Indication (2017-2030)
13.2.9.6. Market Revenue and Forecast, by End-use (2017-2030)
13.2.10. Rest of Europe
13.2.10.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.2.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.2.10.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.2.10.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.2.10.5. Market Revenue and Forecast, by Indication (2017-2030)
13.2.10.6. Market Revenue and Forecast, by End-use (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.3.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.3.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.3.5. Market Revenue and Forecast, by Indication (2017-2030)
13.3.6. Market Revenue and Forecast, by End-use (2017-2030)
13.3.7. India
13.3.7.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.3.7.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.3.7.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.3.7.5. Market Revenue and Forecast, by Indication (2017-2030)
13.3.7.6. Market Revenue and Forecast, by End-use (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.3.8.5. Market Revenue and Forecast, by Indication (2017-2030)
13.3.8.6. Market Revenue and Forecast, by End-use (2017-2030)
13.3.9. Japan
13.3.9.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.3.9.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.9.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.3.9.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.3.9.5. Market Revenue and Forecast, by Indication (2017-2030)
13.3.9.6. Market Revenue and Forecast, by End-use (2017-2030)
13.3.10. Rest of APAC
13.3.10.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.3.10.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.3.10.5. Market Revenue and Forecast, by Indication (2017-2030)
13.3.10.6. Market Revenue and Forecast, by End-use (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.4.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.4.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.4.5. Market Revenue and Forecast, by Indication (2017-2030)
13.4.6. Market Revenue and Forecast, by End-use (2017-2030)
13.4.7. GCC
13.4.7.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.4.7.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.4.7.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.4.7.5. Market Revenue and Forecast, by Indication (2017-2030)
13.4.7.6. Market Revenue and Forecast, by End-use (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.4.8.5. Market Revenue and Forecast, by Indication (2017-2030)
13.4.8.6. Market Revenue and Forecast, by End-use (2017-2030)
13.4.9. South Africa
13.4.9.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.4.9.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.9.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.4.9.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.4.9.5. Market Revenue and Forecast, by Indication (2017-2030)
13.4.9.6. Market Revenue and Forecast, by End-use (2017-2030)
13.4.10. Rest of MEA
13.4.10.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.4.10.2. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.4.10.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.4.10.5. Market Revenue and Forecast, by Indication (2017-2030)
13.4.10.6. Market Revenue and Forecast, by End-use (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.5.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.5.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.5.5. Market Revenue and Forecast, by Indication (2017-2030)
13.5.6. Market Revenue and Forecast, by End-use (2017-2030)
13.5.7. Brazil
13.5.7.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.5.7.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.7.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.5.7.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.5.7.5. Market Revenue and Forecast, by Indication (2017-2030)
13.5.7.6. Market Revenue and Forecast, by End-use (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Animal Type (2017-2030)
13.5.8.2. Market Revenue and Forecast, by Product (2017-2030)
13.5.8.3. Market Revenue and Forecast, by Sample Type (2017-2030)
13.5.8.4. Market Revenue and Forecast, by Testing Category (2017-2030)
13.5.8.5. Market Revenue and Forecast, by Indication (2017-2030)
13.5.8.6. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 14. Company Profiles
14.1. IDEXX Laboratories
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Zoetis
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Virbac
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Heska Corporation
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Thermo Fisher Scientific, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Neogen Corporation
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Mindray
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Esaote SpA
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. FUJIFILM Corporation
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Woodley Equipment Company Ltd.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms